| Dr Melvin Dana Bullock, MD | |
|
11685 Alpharetta Hwy, Suite 320, Roswell, GA 30076-4913 | |
| (770) 442-5882 | |
| (470) 514-3759 |
| Full Name | Dr Melvin Dana Bullock |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 18 Years |
| Location | 11685 Alpharetta Hwy, Roswell, Georgia |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093869786 | NPI | - | NPPES |
| 146KW | Other | FL | BC/BS |
| P00782776 | Other | FL | RR MEDICARE |
| 003101130D | Medicaid | GA | |
| 003101130E | Medicaid | GA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellstar North Fulton Hospital | Roswell, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gastroenterology Consultants,pc | 8628063633 | 3 |
News Archive
For people with family and friends living or travelling in areas affected by the recent disasters in Japan, the British Columbia Psychological Association stands ready to help. Those in BC who are experiencing emotional concerns due to these events in Japan can access the services of the BCPA Disaster Response Network who will provide brief pro bono psychological services to help restore coping skills challenged by the enormity of this disaster.
PhD, RN, FAAN, dean and professor, Graduate School of Nursing, Uniformed Services University, Bethesda, Md., the nation's federal health sciences university — will receive the GE Healthcare-AACN Pioneering Spirit Award.
Arena Pharmaceuticals, Inc. and Eisai Inc. reported today that top-line results from the one-year lorcaserin BLOOM-DM trial demonstrate statistically significant weight loss in obese and overweight patients with type 2 diabetes. In this trial, lorcaserin met all three co-primary efficacy endpoints. In addition, as described below, lorcaserin patients taking lorcaserin 10 mg twice daily (BID) achieved statistically significant improvements in multiple secondary endpoints, including HbA1c, as compared to patients randomized to placebo.
The Association of American Cancer Institutes is excited to announce the launch of a curated online collection of cancer advocacy resources. The AACI Public Policy Resource Library went live today during the 2019 AACI/CCAF Annual Meeting in Washington, DC.
Research carried out at the Peninsula College of Medicine and Dentistry (PCMD), University of Exeter, has concluded that it would be a safe and cost-effective strategy to screen people with type 2 diabetes who have not yet developed diabetic retinopathy, for the disease once every two years instead of annually.
› Verified 8 days ago
| Entity Name | Gastroenterology Consultants,pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568546380 PECOS PAC ID: 8628063633 Enrollment ID: O20040419001066 |
News Archive
For people with family and friends living or travelling in areas affected by the recent disasters in Japan, the British Columbia Psychological Association stands ready to help. Those in BC who are experiencing emotional concerns due to these events in Japan can access the services of the BCPA Disaster Response Network who will provide brief pro bono psychological services to help restore coping skills challenged by the enormity of this disaster.
PhD, RN, FAAN, dean and professor, Graduate School of Nursing, Uniformed Services University, Bethesda, Md., the nation's federal health sciences university — will receive the GE Healthcare-AACN Pioneering Spirit Award.
Arena Pharmaceuticals, Inc. and Eisai Inc. reported today that top-line results from the one-year lorcaserin BLOOM-DM trial demonstrate statistically significant weight loss in obese and overweight patients with type 2 diabetes. In this trial, lorcaserin met all three co-primary efficacy endpoints. In addition, as described below, lorcaserin patients taking lorcaserin 10 mg twice daily (BID) achieved statistically significant improvements in multiple secondary endpoints, including HbA1c, as compared to patients randomized to placebo.
The Association of American Cancer Institutes is excited to announce the launch of a curated online collection of cancer advocacy resources. The AACI Public Policy Resource Library went live today during the 2019 AACI/CCAF Annual Meeting in Washington, DC.
Research carried out at the Peninsula College of Medicine and Dentistry (PCMD), University of Exeter, has concluded that it would be a safe and cost-effective strategy to screen people with type 2 diabetes who have not yet developed diabetic retinopathy, for the disease once every two years instead of annually.
› Verified 8 days ago
| Entity Name | Emory Specialty Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407864168 PECOS PAC ID: 3476559782 Enrollment ID: O20061010000447 |
News Archive
For people with family and friends living or travelling in areas affected by the recent disasters in Japan, the British Columbia Psychological Association stands ready to help. Those in BC who are experiencing emotional concerns due to these events in Japan can access the services of the BCPA Disaster Response Network who will provide brief pro bono psychological services to help restore coping skills challenged by the enormity of this disaster.
PhD, RN, FAAN, dean and professor, Graduate School of Nursing, Uniformed Services University, Bethesda, Md., the nation's federal health sciences university — will receive the GE Healthcare-AACN Pioneering Spirit Award.
Arena Pharmaceuticals, Inc. and Eisai Inc. reported today that top-line results from the one-year lorcaserin BLOOM-DM trial demonstrate statistically significant weight loss in obese and overweight patients with type 2 diabetes. In this trial, lorcaserin met all three co-primary efficacy endpoints. In addition, as described below, lorcaserin patients taking lorcaserin 10 mg twice daily (BID) achieved statistically significant improvements in multiple secondary endpoints, including HbA1c, as compared to patients randomized to placebo.
The Association of American Cancer Institutes is excited to announce the launch of a curated online collection of cancer advocacy resources. The AACI Public Policy Resource Library went live today during the 2019 AACI/CCAF Annual Meeting in Washington, DC.
Research carried out at the Peninsula College of Medicine and Dentistry (PCMD), University of Exeter, has concluded that it would be a safe and cost-effective strategy to screen people with type 2 diabetes who have not yet developed diabetic retinopathy, for the disease once every two years instead of annually.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Melvin Dana Bullock, MD 11685 Alpharetta Hwy, Suite 320, Roswell, GA 30076-4913 Ph: (770) 442-5882 | Dr Melvin Dana Bullock, MD 11685 Alpharetta Hwy, Suite 320, Roswell, GA 30076-4913 Ph: (770) 442-5882 |
News Archive
For people with family and friends living or travelling in areas affected by the recent disasters in Japan, the British Columbia Psychological Association stands ready to help. Those in BC who are experiencing emotional concerns due to these events in Japan can access the services of the BCPA Disaster Response Network who will provide brief pro bono psychological services to help restore coping skills challenged by the enormity of this disaster.
PhD, RN, FAAN, dean and professor, Graduate School of Nursing, Uniformed Services University, Bethesda, Md., the nation's federal health sciences university — will receive the GE Healthcare-AACN Pioneering Spirit Award.
Arena Pharmaceuticals, Inc. and Eisai Inc. reported today that top-line results from the one-year lorcaserin BLOOM-DM trial demonstrate statistically significant weight loss in obese and overweight patients with type 2 diabetes. In this trial, lorcaserin met all three co-primary efficacy endpoints. In addition, as described below, lorcaserin patients taking lorcaserin 10 mg twice daily (BID) achieved statistically significant improvements in multiple secondary endpoints, including HbA1c, as compared to patients randomized to placebo.
The Association of American Cancer Institutes is excited to announce the launch of a curated online collection of cancer advocacy resources. The AACI Public Policy Resource Library went live today during the 2019 AACI/CCAF Annual Meeting in Washington, DC.
Research carried out at the Peninsula College of Medicine and Dentistry (PCMD), University of Exeter, has concluded that it would be a safe and cost-effective strategy to screen people with type 2 diabetes who have not yet developed diabetic retinopathy, for the disease once every two years instead of annually.
› Verified 8 days ago
Chirag D Popat, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4500 Hospital Blvd Ste 310, Roswell, GA 30076 Phone: 770-410-4366 Fax: 770-410-4664 | |
Neeta J Patel, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 11205 Alpharetta Hwy Ste B-6a, Roswell, GA 30076 Phone: 770-753-4884 Fax: 770-753-0507 | |
Dr. William Bizzaro, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 2500 Hospital Blvd, Suite 480, Roswell, GA 30076 Phone: 770-475-3085 Fax: 770-343-8127 | |
Priya C Palliyil, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1240 Upper Hembree Rd, Ste D, Roswell, GA 30076 Phone: 770-667-0810 Fax: 678-288-7942 | |
Dr. Ognjenka Goga Brkic-vukotic, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 11050 Crabapple Rd, Suite 104 B, Roswell, GA 30075 Phone: 770-645-0017 Fax: 770-645-0224 | |
Dr. Jatin Patel, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 11731 Pointe Pl, Roswell, GA 30076 Phone: 770-284-3150 | |
Ashly Elizabeth Joseph, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 11731 Pointe Pl, Roswell, GA 30076 Phone: 770-284-3150 Fax: 770-284-3170 |